
- Mount Sinai Doctors
- Video Visit Available
- Accepting New Patients
Peter Wiklund, MD, PhD
Urology
About Me
Dr. Peter Wiklund is Professor of Urology, Department of Urology at the Icahn School of Medicine at Mount Sinai, and Director of the Bladder Cancer Program of the Mount Sinai Health System. Prior to his appointment at Mount Sinai, Dr. Wiklund was Chair, Urology and Molecular Medicine and Surgery, and Professor, Urology, at the Karolinska Instutet, Stockholm, Sweden.
Dr. Wiklund has the largest experience with robot-assisted cystectomy with totally intracorporeal neobladder in the world. He pioneered this procedure in 2003 and subsequently built the leading cystectomy program at Karolinska Institute. Dr. Wiklund has performed more than 3,000 robotic operations and has extensive experience in advanced pelvic oncological surgery in patients where the tumor is growing on several pelvic organs (multi-organ tumor, bladder, prostate, colorectal, ovarian, and uterine).
Dr. Wiklund travels the world as an invited lecturer at various courses and master classes in robotic surgery. He has performed live educational surgery in most European countries, as well as in Asia and South America. Dr. Wiklund is Chairman of the scientific working group of the European Urology Robotic Section of the European Association of Urology and is an international member of the American Urological Association. He has been chairman of many international courses on bladder cancer and prostate cancer surgery.
Throughout his career, Dr. Wiklund has been a productive investigator who has made important original contributions in the area of Physiology and Pharmacology as well as Urology and coordinated several multi-institutional studies. He has published over 300 peer-reviewed original publications and 30 review articles and has been the editor and contributing author of three textbooks on robot-assisted surgery. He has also contributed to numerous textbooks in Oncological Urology.
Having successfully built a career that combines clinical practice and original research, Dr. Wiklund is known as a role model for young investigators. He is an extraordinary mentor who has guided many residents, fellows as well as junior faculty to successful careers in research and clinical medicine. Dr. Wiklund organized the successful international fellowship program in robot-assisted surgery at Karolinska University Hospital where urologists from all over the world have trained.
Language
English, Swedish
Position
PROFESSOR | Urology
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Bladder Cancer
- Cystectomy
- Cystoscopy
- Elevated PSA
- Prostate Biopsy
- Prostate Cancer
- Prostate-Specific Antigen (PSA) Test
- Prostatectomy
- Radical Cystectomy
- Robotic Prostate Surgery
Education
MD, Karolinska Institutet
Internship, Urology
Capio St. Goran Hospital
Residency, Urology
Karolinska University Hospital
Certifications
American Board of Urology
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) or Molina insurance: please visit the linked pages in this message before booking to find out if out-of-network costs may apply to your next visit.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Long-term oncological outcomes of bladder cancer: a population-based study with a 25-year follow-up. Linda Dey, Juhana Rautiola, Olof Akre, Lars Egevad, Abolfazl Hosseini, Reza Mehrazin, Jaakko Patrakka, Daniel Ranti, Lotta Renström-Koskela, John Sfakianos, Tomas Thiel, Per Henrik Vincent, Jane Yan, Gunnar Steineck, Peter Wiklund. BJU International
- Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial. Hari T. Vigneswaran, Thorgerdur Palsdottir, Chiara Micoli, Derya Tilki, Daniel Lin, Matthew Cooperberg, Scott Eggener, Ugo Giovanni Falagario, Axel Möller, Markus Aly, Olof Akre, Peter Wiklund, Lars Egevad, Henrik Grönberg, Tobias Nordström, Martin Eklund. European Urology
- Bladder Cancer with Undetectable Circulating Tumor DNA After Radical Cystectomy May Be Amenable to a Less Intense Imaging Surveillance Protocol: A Diagnostic Accuracy Study. Ahmed Eraky, Reuben Ben-David, Brenda Hug, Kaushik P. Kolanukuduru, Mohammed Almoflihi, Nikhil Waingankar, Kyrollis Attalla, Peter Wiklund, Reza Mehrazin, John P. Sfakianos. European urology oncology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Wiklund has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.